Intranasal Therapy Could Slow Parkinson’s Progression
Summary: Researchers at Rush University Medical Center report that two intranasal peptides reduced brain inflammation and halted the spread of alpha-synuclein in mouse models of Parkinson’s disease. Treated animals also showed measurable improvements in gait, balance, and other motor functions. If these findings translate to humans, the investigators say the approach could represent a significant … Read more